Non-small Cell Lung Cancer (NSCLC) Stage IV
3 clinical trials · Condition
◉ Watch Non-small Cell Lung Cancer (NSCLC) Stage IV
| Record | Firm | Date |
|---|---|---|
| A Study to Evaluate the Safety and Efficacy of Ex Vivo Expanded Autologous Immune Killer Cells (IKC) in Stage IV Non-small Cell Lung Cancer (NSCLC) in Patients Who Failed Chemotherapy or Target Therapy (NCT03499834) | Ivy Life Sciences, Co., Ltd | 2017-12-05 |
| A Phase III Trial of Recombinant Human Apo-2 Ligand for Injection (NCT03083743) | Shanghai Gebaide Biotechnology Co., Ltd. | 2016-10-01 |
| Phase 1 Erlotinib and Dovitinib (TKI258) in Advanced Non-small Cell Lung Cancer (NSCLC) (NCT01515969) | Heather Wakelee | 2012-07-01 |
Track Non-small Cell Lung Cancer (NSCLC) Stage IV automatically
Every clearance here is in the API, with alerts when new ones post.